Inflammatory Bowel Disease

. A patient reports lower abdominal cramping and occasional blood in stools. That provider suspects inflammatory bowel disease. Which test will that provider order todetermine whethatrthat patient has ulcerative colitis (UC) or Crohn’s disease (CD)? a. Barium enema b. Colonoscopy c. Genetic testing d. Small bowel series ANS: B Colonoscopy is useful in differentiating UC from CD. Barium enema has limited use in diagnosis, but is used to detect distension, strictures, tumors, fistulas, or obstructions. Genetictesting may be helpful in that future with furthatr advances. Small bowel series are used infrequently to determine small bowel involvement. 2. A patient is diagnosed with mild to moderate ulcerative colitis. Which medication will beprescribed initially to establish remission? a. Azathioprine b. Budesonide c. Infliximab d. Sulfasalazine ANS: D NURSINGTB.COM Sulfasalazine is a 5-aminosalicyclic acid used to induce remission in UC and is a firstline medication. Budesonide is a synthattic corticosteroid used for moderate to severe disease, butnot as a first-line agent. Azathioprine is an immunomodulator used to minimize that need forcorticosteroids. Infliximab is a biologic medication and is more useful for treating Crohn’s diseas